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Abstract— miRNA and gene expression profiles have been 
proved useful for classifying cancer samples. Efficient classifiers 
have been recently sought and developed.  A number of attempts 
to classify cancer samples using miRNA/gene expression profiles 
are known in literature. However, the use of semi-supervised 
learning models have been used recently in bioinformatics, to 
exploit the huge corpuses of publicly available sets. Using both 
labeled and unlabeled sets to train sample classifiers, have not 
been previously considered when gene and miRNA expression sets 
are used. Moreover, there is a motivation to integrate both miRNA 
and gene expression for a semi-supervised cancer classification as 
that provides more information on the characteristics of cancer 
samples.  
In this paper, two semi-supervised machine learning 
approaches, namely self-learning and co-training, are adapted to 
enhance the quality of cancer sample classification. These 
approaches exploit the huge public corpuses to enrich the training 
data. In self-learning, miRNA and gene based classifiers are 
enhanced independently. While in co-training, both miRNA and 
gene expression profiles are used simultaneously to provide 
different views of cancer samples. To our knowledge, it is the first 
attempt to apply these learning approaches to cancer 
classification. The approaches were evaluated using breast cancer, 
hepatocellular carcinoma (HCC) and lung cancer expression sets. 
Results show up to 20% improvement in F1-measure over 
Random Forests and SVM classifiers. Co-Training also 
outperforms Low Density Separation (LDS) approach by around 
25% improvement in F1-measure in breast cancer. 
Keywords— miRNA and gene expression analysis; Semi-
supervised Approaches; Self-Learning; Co-Training; Cancer sample 
classifiers 
I.  INTRODUCTION 
MicroRNAs (miRNAs) are short (19–25 nucleotides)   
noncoding single-stranded RNA molecules [1], which are 
cleaved from 70–100 nucleotide miRNA precursors. miRNAs 
regulate gene expression either at the transcriptional or 
translational level, based on specific binding to the 
complementary sequence in the coding or noncoding region of 
mRNA transcripts [1]. Recent research has pointed out the 
success of using miRNA and gene expression datasets in cancer 
classification; miRNA profiles were used recently to 
discriminate malignancies of the breast [2], lung ([2], [3]), 
pancreas ([2], [4]) and liver ([5], [6], [7]). Enhancing the 
accuracy of cancer classifiers, based on miRNA, gene, or mRNA 
expressions, has been targeted in previous work ([8], [9], [10], 
[11], [12], [13]). Moreover, different feature selections and 
classification methods that efficiently detect the malignancy 
status (normal or cancer) of the tissues were previously explored 
in [11]. In addition, two classifiers are built [12], one for miRNA 
data and another for mRNA data. The main drawbacks of the 
approach is that it assumes paired miRNA and mRNA data for 
each patient and it uses decision fusion rule to combine the 
classifiers decision without enhancing the classifiers 
themselves. Random Forests have been used in classifying 
cancer in [14], [15] and [16]. Also, SVM has been used in 
classifying cancer as in [17] and [18]. 
The idea of combining both labeled and unlabeled sets using 
semi-supervised machine learning approaches has been used to 
enhance classifiers in other domains like object detection [22], 
word sense disambiguation [23] and subjective noun 
identification [24]. Semi-supervised learning also has proved to 
be effective in solving several biology problems like protein 
classification [25] and prediction of factor-gene interaction [26]. 
However, in the field of sample classification using gene and 
miRNA expression, semi-supervised machine learning 
techniques were not considered before. Microarray experiments 
are time consuming, expensive and limited, that is why usually 
the number of samples of microarray-based studies is small [27]. 
Thus, huge publicly available gene/miRNA expression sets with 
unlabeled samples are tempting to use for enriching training data 
of sample classifiers. Integrating both miRNA and mRNA 
expression profiles were thought to provide complementary 
information [12], as miRNAs regulate gene expression at the 
post-transcriptional level. In co-training, both miRNA and gene 
expression profiles are used simultaneously to provide different 
views of cancer samples.  Semi-supervised machine learning 
approaches are applied in this paper to discriminate cancer 
subtypes. Discriminating cancer subtypes helps in 
understanding the evolution of cancer and is used to find 
appropriate therapies. For example, angiogenesis inhibitors like 
bevacizumab are more effective in treating adenocarcinoma 
lung cancer than squamous phenotypes ([19], [20]). Also, breast 
cancer has an unpredictable response, and developing effective 
therapies remain a major challenge in the clinical management 
of breast cancer patients [21]. Moreover, identifying metastasis 
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hepatocellular carcinoma (HCC) samples is an important task as 
metastasis is a complex process that involves multiple 
alterations ([39], [40]).  
   In this paper, two semi-supervised machine learning 
approaches, namely self-learning [28] and co-training ([29], 
[30]) are used to enhance the classification accuracy of cancer 
samples by combining both labeled and unlabeled miRNA and 
gene expression profiles. In self-learning, a classifier is initially 
constructed using the labeled set, then its accuracy is enhanced 
by adding more data from unlabeled sets. Self-learning is used 
on one particular source of expression, i.e either gene or miRNA 
expression data. In co-training, two classifiers are trained, each 
is specific to a different source of expression data (gene or 
miRNA), termed as two views of the data. Based on the two 
views, two classifiers are constructed and then used to train each 
other. Exchanging information between the two classifiers 
requires a mapping from miRNA expression to gene expression 
or the opposite. A simple mapping is thus suggested based on 
known biological relations between miRNAs and their target 
genes. 
   The aforementioned classification approaches were 
evaluated using gene and miRNA expression profiles of three 
different cancer types: breast cancer, hepatocellular carcinoma 
(HCC) and lung cancer. The results show around 20% 
improvement in F1-measure in breast cancer, around 10% 
improvement in precision in metastatic HCC cancer and 3% 
improvement in F1-measure in squamous lung cancer over the 
Random Forests and SVM classifiers. Also, the approaches were 
compared to another semi-supervised approach called Low 
Density Separation (LDS), which was used to enhance the 
classifiers of cancer recurrence in [27]. The results show that co-
training outperforms LDS by exploiting the two different views, 
i.e. miRNA expression view and gene expression view.    
   The paper is organized as follows section II discusses the 
related work, while section III describes the proposed 
approaches in details and section IV shows experimental results. 
Finally section V concludes the paper. 
II. RELATED WORK 
 Using miRNA expression profiles to discriminate cancerous 
samples from normal ones, and to classify cancer into its 
subtypes, is an active research area and was applied to different 
cancer types as breast [2], lung ([2], [3]), pancreatic in ([2], [4]) 
and liver in ([5], [6], [7]). The previous papers used one of the 
following supervised machine learning techniques like SVM, 
Prediction Analysis of Microarrays (PAM) and compound 
covariate predictor. 
Several attempts for enhancing cancer classifiers have been 
recently introduced ([11], [12], [13]). In [11], number of feature 
selection methods, as Pearson’s and Spearman’s correlations, 
Euclidean distance, cosine coefficient, information gain and 
mutual information and signal-to-noise ratio are used to enhance 
cancer classifiers. Also different classification methods which 
are k-nearest neighbor methods, multilayer perceptrons, and 
support vector machines with linear kernel are used [11]. The 
work has focused only on improving classifiers based on labeled 
samples miRNA expression profiles and didn’t use publicity 
available unlabeled sets, also, gene expression profiles were not 
used to enhance miRNA based cancer samples classifiers. 
Enhancing the classification accuracy by building two classifiers 
one for miRNA data and another for mRNA data were explored 
in [12]. That work first applies feature selection using relief-F 
feature selection, then it uses bagged fuzzy KNN classifier and 
finally it combines the two classifiers using fusion decision rule. 
The drawback of the approach is that it assumes the existence of 
both miRNA and mRNA data for each patient and it just uses 
decision fusion rule to combine the classifiers decision without 
enhancing the classifiers themselves. Another work [13] has 
considered using discrete function learning (DFL) method on the 
miRNA expression profiles to find the subset of miRNAs that 
shows strong distinction of expression levels in normal and 
tumor tissues and then uses these miRNAs to build a classifier. 
The paper didn’t combine multiple miRNA dataset or use gene 
expression dataset to enhance the classifier. Semi-supervised 
machine learning approaches were introduced in classification 
using expression sets by using LDS approach which was used in 
[27] to enhance cancer recurrence classifiers. Semi-supervised 
machine learning approaches make use of the publicity available 
unlabeled sets to enrich the training data of the classifiers. 
However, the approach depends only on gene expression, and 
didn’t combine both miRNA and gene expression sets.  
Other semi-supervised machine learning approaches like 
self-learning and co-training were introduced in other domains. 
The heuristic approach of self-learning (also known as self-
training) is one of the oldest approaches in semi-supervised 
learning and that was introduced in [28]. Self-learning was used 
in many applications as object detection [22], word sense 
disambiguation [23] and subjective noun identification [24]. 
Also, co-training is a semi-supervised approach that appeared in 
[29] and [30] and is also used in applications as word sense 
disambiguation [31] and email classification [32]. 
 In this paper, self-learning and co-training approaches are 
used. Both approaches use unlabeled sets to enhance classifiers 
accuracy. Co-training also enhances the results by combining 
both miRNA and gene expression sets. The results show 
improvements over Random Forests and SVM classifiers and 
LDS approach.  
III. SELF-LEARNING AND CO-TRAINING ADAPTATION TO 
MIRNA/GENE BASED CLASSIFICATION 
In self-learning and co-training, the objective is to construct 
a classifier to discriminate between different cancer subtypes, 
given the following: 
 The expression vector of a sample i, denoted xi, is 
defined as follows:  
𝑥𝑖 = {𝑒𝑖1, 𝑒𝑖2, … , 𝑒𝑖𝑗 , … , 𝑒𝑖𝑀} 
Where 𝑒𝑖𝑗 is the expression value of the j
th 
miRNA/gene, and M is the number of 
miRNAs/genes. 
 N is the number of samples. 
Two sets are used in both self-learning and co-training, 
which are defined as follows: 
 A set of labeled samples L; 𝐿 = {𝑥𝑖, 𝑦𝑖}𝑖=1
𝑁  
Where yi is the cancer subtype label. 
 A set of unlabeled samples U; 𝑈 = {𝑥𝑖}𝑖=1
𝑁  
The size of U is expected to be much larger than L (|U| >> 
|L|), which is expected to help enhancing the accuracy of the 
classifiers by adding more expression vectors to the training 
data. Increasing the number of unlabeled sets leads to higher 
enrichment in the training set. Moreover, increasing the overlap 
between the miRNAs/genes in the labeled and unlabeled sets 
leads to increasing the effect of adding the unlabeled sets.  
Self-learning [28] is a semi-supervised machine learning 
approach, in which the labeled set L is used to build the initial 
classifier and the unlabeled set U is utilized to enhance its 
accuracy by adding the unlabeled samples with the highest 
classification confidence to the training set, thus resulting in 
making the classifier learns based on its own decision. Co-
training ([29], [30]) is also a semi-supervised machine learning 
approach, which requires two views of the data. Two classifiers 
are constructed separately for each view. Each classifier is then 
used to train the other one by classifying unlabeled samples and 
train the other view with the samples with highest classification 
confidence. 
The next sections explain how the two approaches are 
adapted to use the unlabeled set U to enhance the baseline 
classifier constructed based on L. 
A. Self-Leanring Adaptation  
 The steps of adapting the self-learning approach are 
described as follows: 
a) Train an initial cancer subtype classifier using set L. 
b) Use the initial classifier to identify the subtype labels 
of the unlabeled set U. 
c) Choose the most confident subset of cancer samples 
(U'), i.e. samples classified with a confidence greater 
than a given threshold (α).  
d) Append the set of most confident samples to the initial 
training dataset to form a new training set (U' ∪ L) for 
re-training the classifier. 
e) Use the classifier constructed at step d to perform 
several iterations over the unlabeled set(s). At each 
iteration, re-apply steps b, c and d. 
The resulting classifier can then be used to classify new 
samples based on their miRNA/gene expression profiles.      
The confidence threshold α should be appropriately selected. 
Decreasing α can increase the false positives rate. On the other 
hand, increasing α can result in restricting the learning process 
to the highly confident samples, typically the ones that are 
most similar to the training data, thus losing the benefit of 
including more training samples to the labeled data. Tuning 
parameter α is thus important, since it affects the classifier’s 
accuracy to choose the samples that will enhance the 
classifier.    
      The next section explains the co-training idea and 
adaptation in details. 
 
B. Co-Training Adaptation 
In this paper, the co-training approach is adapted to classify 
cancer subtypes by training two different classifiers; the first is 
based on the gene expression view and the second is based on 
the miRNA expression view. Each view captures a different 
perspective of the underlying biology of cancer and integrating 
them using the co-training pipeline exploits this information 
diversity to enhance the classification accuracy. The following 
steps describes co-training in details: 
a) Two initial cancer classifiers are separately 
constructed; one from the miRNA expression 
dataset (LmiRNA) and another one from the gene 
expression dataset (Lgene) using manually labeled 
cancer subtypes sets. 
b) Let the initial classifiers separately classify the 
unlabeled cancer miRNA/gene expression datasets 
(UmiRNA/ Ugene) into cancer subtypes. 
c) Choose the most confident labeled subtypes 
samples (U'miRNA& U'gene) that have classification 
scores greater than α. 
d) Retrieve miRNA-gene relations using miRanda. 
For the classifiers to train each other, miRNA 
expression should be mapped to gene expression 
and vice versa. miRNAs and their target genes 
databases are used to map the datasets. In our case, 
miRanda [33] database is used. 
e) Append the mapped miRNA expression sets to the 
gene expression training sets and the mapped gene 
expression sets to the miRNA expression training 
sets and re-train the classifiers. 
 
 
 
Fig 1. Self-Learning approach overview. 
 
 
f) Use the classifier constructed at step e to perform 
several iterations over the unlabeled set(s). At each 
iteration, re-apply steps b, c, d and e. 
g) In step d, a mapping between the miRNA view and 
gene view is required. As shown in figure 2, 
miRNAs and their target genes are related by a 
many to many relationship; multiple miRNAs 
target the same gene, and multiple genes are 
targeted by the same miRNA. For the classifier to 
exploit the two views, i.e. gene and miRNA sets, a  
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 2. miRNAs and their target genes are related 
by a many to many relationship. The first column 
represents miRNAs and the second column 
represents target genes ids. 
miRNA expression vector is constructed from its 
target gene’s expression vector.. Due to the many 
to many relationship between miRNAs and genes, 
it is suggested to use an aggregation of all 
expression vectors of the target genes to represent 
the miRNA expression vector. Similarly, a gene 
expression vector is constructed by aggregating the 
expression vectors of the miRNAs that target this 
gene. To map a gene to a miRNA, or the opposite, 
it is proposed to take the mean expression value of 
all miRNAs related to a gene, or the opposite, i.e. 
the mean expression value of all genes related to a 
miRNA. Experimental results show that taking the 
mean value of expressions has improved the 
classification accuracy. Part of the future work 
would be investigating the effect of using other 
methods as a mapping function.  
    After the co-training process, the two classifiers can be 
used independently, one on gene expression profile and the 
other on miRNA expression profile of cancer samples. The 
next section shows the experimental results of both self-
learning and co-training approaches. 
IV. EXPERIMENTAL RESULTS 
Two core classifiers of self-learning and co-training were 
used, which are Random Forests and SVM. RF is a known 
classifier ensemble method [34] based on constructing multiple 
decision trees. Each decision tree is built on a bootstrap sample 
of the training data using a randomly selected subset of features. 
For predicting a sample's label, a majority vote based on the 
classification obtained from the different decision trees is 
calculated. RF have been used in classifying cancer in [14], [15] 
and [16]. RF implementation from the Weka repository [35] was 
used, and the number of decision trees was set to 10. SVM 
implementation was also used from the Weka repository [35]. 
The approaches were evaluated using three cancer types, 
namely breast cancer, hepatocellular carcinoma (HCC) and lung 
cancer. miRNA based classifiers were constructed for breast 
cancer and HCC sets, while gene based classifiers were 
constructed for all 3 sets. In addition, self-learning and co-
training were compared against LDS in breast cancer and HCC. 
LDS Matlab implementation was downloaded from [41]. Tables 
1 and 2 show the size of the training and testing sets for each 
cancer type according to its subtypes. All miRNA and gene 
expression profiles were downloaded from NCBI [36]. 
Moreover, table 3 shows sample size and miRNA/gene numbers 
in the unlabeled sets. 
Table 1. Training and testing samples size for breast cancer 
and HCC subtypes using miRNA expression. (NM = non-
metastatic and M = metastatic) 
Type Breast Cancer (GSE15885) HCC 
(GSE6857) 
Subtype ER+/ 
Her2
- 
ER-/ 
Her2
+ 
ER-/ 
Her2- 
ER+/ 
Her2
+ 
NM  M 
Train  8 2 5 1 193 62 
Test 7 2 4 0 162 65 
 
Co-training ( LmiRNA,  UmiRNA ,  Lgene ,  Ugene,  α) 
Inputs:  miRNA expression profile of labeled set (LmiRNA), 
miRNA expression profile of unlabeled sets (UmiRNA ), 
gene expression profile of labeled set (Lgene), gene 
expression profile of unlabeled sets (Ugene) and confident 
threshold (α) 
Outputs: Two classifiers (CmiRNA) and (Cgene) that can 
separately classify cancer samples. 
Begin 
Repeat { 
1. CmiRNA = TrainClassifier (LmiRNA) 
2. Cgene = TrainClassifier (Lgene) 
3. L’miRNA = Classify (CmiRNA, UmiRNA) 
4. LαmiRNA= ChooseMostConfident(L’miRNA,  α) 
5. L’gene = Classify (Cgene, Ugene). 
6. Lαgene= ChooseMostConfident(L’gene,  α). 
7. LmiRNA =  LmiRNA U ConverToMiRNAs(Lαgene)  
8. Lgene =  Lgene U ConverToGenes(LαmiRNA) 
} Until (no improvement in classification 
accuracy or reaching max iterations) 
End 
Fig 3. Pseudo code of co-training approach. 
Table 2. Training and testing sample size for breast cancer, 
HCC and lung cancer subtypes using gene expression. (NM = 
non-metastatic, M = metastatic, A = adenocarcinoma and S = 
squamous) 
Type Breast Cancer (GSE20713) HCC Lung 
Sub 
Type 
ER+/ 
Her2
- 
ER-/ 
Her2 
+ 
ER-/ 
Her2
- 
ER+/ 
Her2 
+ 
N
M 
M A S 
Train 17 9 14 4 98 118 87 41 
Test 17 8 14 4 98 120 86 40 
 
Table 3. Sample size and miRNA/gene numbers of unlabeled 
sets. 
 Sample 
Size 
miRNA/gene 
Numbers 
Breast Cancer (GSE26659) 94 237 miRNAs 
Breast Cancer (GSE35412) 35 378 miRNAs 
Breast Cancer (GSE16179) 19 54675 genes 
Breast Cancer (GSE22865) 12 54675 genes 
Breast Cancer (GSE32161) 6 54675 genes 
HCC (GSE10694) 78 121 miRNAs 
HCC (GSE15765) 90 42718 genes 
Lung Cancer (GSE42127) 176 48803 genes 
 
 
 
Table 4. Precision, recall and F1-measure for breast cancer 
subtypes RF classifiers using miRNA expression and gene 
expression dataset. 
 miRNAs based 
classifier 
Genes based 
classifier 
P R F1 P R F1 
Baseline 
classifier 
28.9 53.9 37.7 40.8 44.2 42.5 
Self-learning 
iteration 1 
31.4 53.9 39.7 54.6 58.1 56.3 
Self-learning 
iteration 2 
46.8 61.5 53.2 - - - 
Co-training 56.9 61.5 59.1 44.7 53.5 48.7 
 
Table 5. Precision, recall and F1-measure for breast cancer 
subtypes SVM classifiers using miRNA expression and gene 
expression dataset. 
 miRNAs based classifier 
P R F1 
Baseline SVM 
classifier 
24.5 38.5 29.9 
LDS 42.3 30.8 35.6 
Self-Learning 31.4 53.8 39.7 
Co-Training 62.2 61.5 61.9 
 
A. Breast Cancer  
Breast cancer is a heterogeneous disease that has a range 
of phenotypically distinct tumor types. This heterogeneity has 
an underlying spectrum of molecular alterations and initiating 
events that was found clinically through a diversity of disease 
presentations and outcomes [21]. Due to the complexity of 
 
 
 
 
Fig 4. Training data size comparison of initial RF classifier against self-learning and co-training on breast cancer using miRNA 
expression sets. (Class 0 is ER+/Her2-, class 1 is ER-/Her2+, class 2 is ER-/Her2- and class3 is ER+/Her2+) 
 
0
5
10
15
20
25
30
Class 0 Class 1 Class 2 Class 3
Initial RF Classifier Self-Learning Co-Training
this type of tumor, there is a demand for an efficient 
classification of breast cancer samples. 
For breast cancer, both self-learning and co-training are 
used. Self-learning was applied for both miRNA and gene 
based classifiers. For sample classification using miRNA 
expression dataset, an initial breast cancer subtype labeled 
dataset (GSE15885) was used to build an initial cancer 
subtype classifier. The initial classifier was then used to 
predict the labels of the unlabeled breast cancer subtypes 
(GSE26659 and GSE35412).Two iterations were performed 
over the two unlabeled datasets. The confident samples, the 
ones with classification confidence (α) greater than 0.9 were 
added to the training dataset and the subtype classifier was 
re-trained. The same operation was repeated for sample 
classification using gene expression dataset where the initial 
dataset (GSE20713) was used to build an initial classifier 
and the unknown subtype breast cancer (GSE16179) was 
used to enrich it. Table 4 shows the precision, recall and F1-
measure enhancement against the RF classifier. The results 
show 12% improvement in F1-measure of breast cancer 
subtype classifier using miRNA expression profiles and 6% 
improvement in F1-measure of breast cancer subtype 
classifier using gene expression profiles.  Moreover, table 5 
shows the enhancement over SVM and LDS classifiers, only 
miRNA expression profiles were used in this comparison as 
LDS requires a lot of memory and thus was unable to use 
with large number of genes.  The table shows that self-
learning achieved 10% improvement in F1-measure over 
SVM classifier and 4% improvement in F1-measure over 
LDS classifier.  
Co-training was evaluated in breast cancer subtypes in 
both miRNA expression and gene expression. To enhance 
sample classification using miRNA expression, one labeled 
miRNA expression dataset (GSE15885) is used. One labeled 
gene expression dataset (GSE20713) and three unlabeled 
gene expression datasets (GSE16179, GSE22865 and 
GSE32161) are mapped into miRNA expression values (as 
explained in subsection B of section III). In addition, to 
enhance sample classification using gene expression, one 
labeled gene expression dataset (GSE20713) is used. One 
labeled miRNA expression dataset (GSE15885) and two 
unlabeled miRNA expression datasets (GSE26659 and 
GSE35412) are mapped into gene expression values and 
added to the gene training dataset. Table 4 shows the 
significant improvements in F1-measure using co- training 
over RF classifier. Increments up to 21% and 8% in F1-
measure are observed when using miRNA expression 
profiles and gene expression profiles respectively. 
Moreover, table 5 shows the enhancement of co-training 
over SVM and LDS classifiers, co-training was able to 
enhance the F1-measure by around 25% over the LDS 
classifier. 
 To have a closer look on the behavior of the methods, 
the number of training data at each class is determined and 
shown at figure 4. The figure shows that co-training was able 
to enrich the training data in all 4 classes which is reflected 
in the highest improvement in the results and self- learning 
was able to enrich that training set in class 0. 
B. HCC  
Hepatocellular carcinoma (HCC) represents an 
extremely poor prognostic cancer that remains one of the 
most common and aggressive human malignancies 
worldwide ([37], [38]). Metastasis is a complex process that 
involves multiple alterations ([39], [40]), that is why 
discriminating metastasis and non-metastasis HCC is a 
challenging problem. 
For HCC, both self-learning and co-training approaches 
were evaluated to discriminate between metastatic and non- 
metastatic HCC. The self-learning steps are applied using 
GSE6857 as an initial labeled miRNA expression dataset 
and GSE10694 as the unlabeled subtypes HCC samples. 
Also, GSE36376 was used as initial labeled gene expression 
datasets and GSE15765 as the unlabeled subtypes HCC 
samples. For co-training, to enhance sample subtype 
classifier using miRNA expression, one labeled miRNA 
expression dataset (GSE6857) is used. One labeled gene 
expression dataset (GSE36376) and one unlabeled gene 
expression datasets (GSE15765) are mapped into miRNA 
expression values and added to the miRNA training datasets 
and the sample subtype classifiers are re-trained. Also, in 
order to enhance the sample classification using gene 
expression, one labeled gene expression dataset (GSE36376) 
is used. One labeled miRNA expression dataset (GSE6857) 
and one unlabeled miRNA expression datasets (GSE10694) 
are mapped into gene expression datasets and added to the 
gene training dataset.  
 Table 6 shows detailed results for HCC subtype 
classification using RF core classifier, there is around 10% 
improvement in precision of HCC metastasis class using 
miRNA expression sets and around 2% in F1-measure using 
gene expression sets. Moreover, table 7 shows the 
improvement of the techniques over SVM and LDS 
classifiers. Co-training achieved 5% enhancement in recall 
over SVM classifier and 6% enhancement in F1-measure 
over LDS classifier. The improvement in HCC is less than 
breast cancer as in breast cancer the number of used 
unlabeled sets are larger. Also, the overlapping between the 
miRNAs and genes between the initial set and the added sets 
is an important factor. In order to understand why 
enhancements in breast cancer were more significant, the 
number of overlapping miRNAs and genes is calculated. 
Tables 8 and 9 show that the higher the overlap between the 
miRNAs and genes of the initial set and those of the added 
sets, the higher the improvements become. 
C. Lung Cancer  
  Lung cancer is the leading cause of cancer-related death in 
both men and women worldwide, it results in over 160,000 
deaths annually [8]. Only self-learning using gene 
expression dataset was evaluated in lung cancer as no labeled 
miRNA expression dataset was found on the web. The aim 
of the cancer subtype classifier is to discriminate between 
adenocarcinoma and squamous lung cancer subtypes. The 
labeled gene expression dataset (GSE41271) was used to 
build an initial classifier and the unlabeled gene expression 
dataset (GSE42127) was used to enhance it. Table 10 shows 
the enhancement achieved by self-learning, which is around 
3% improvement in F1-measure of squamous lung cancer 
class. 
Table 6. Results of HCC RF subtype classifiers using 
miRNA/gene expression dataset. 
 Class NM Class M Weighted 
Evaluation 
P R F1 P R F1 P R F1 
miRNA
initial 
classifie
r 
75 93 83  59 24 34 70 73 72 
miRNA 
self-
learning 
76 95 84 69 24 36 74 75 74 
miRNA 
co-
training 
76.6 95 84.9 69 27 39 74 75 75 
Genes 
initial 
classifie
r  
95 98 96 98 95 97 96 96 96 
Genes 
self-
learning 
100 96 98 97 100 98 98 98 98 
 
Table 7. Results of HCC subtype SVM classifiers using 
miRNA expression dataset. 
 
Table 8. The number of overlapping miRNAs and genes 
between initial datasets and added datasets in breast cancer. 
 miRNAs initial dataset 
(GSE15885) 
Genes initial dataset 
(GSE20713) 
GSE15885 336 7 
GSE26659 124 7 
GSE35412 183 7 
GSE20713 157 54676 
GSE16179 157 54676 
 
Table 9. The number of overlapping miRNAs and genes 
between initial datasets and added datasets in HCC. 
 miRNAs initial dataset  
(GSE6857) 
Genes initial dataset 
(GSE36376) 
GSE10694 36 - 
GSE36376 52 47323 
GSE15765 52 37282 
 
 
Table 10. Results of lung cancer RF subtypes classifiers using 
gene expression dataset. 
 Class A Class S Weighted 
Evaluation 
P R F1 P R F1 P R F1 
Genes 
initial 
classifier  
83 95 89 83 54 65 83 83 83 
Genes 
self-
learning 
84 96 90 87 56 68 85 85 85 
 
V. CONCLUSION 
   In this paper, two semi-supervised machine learning 
approaches were adapted to classify cancer subtype based on 
miRNA and gene expression profiles. They both exploit the 
expression profiles of unlabeled samples to enrich the 
training data. The miRNA-gene relation is additionally used 
to enhance the classification in co-training. Both self-
learning and co-training approaches improved the accuracy 
compared to Random Forests and SVM as baseline 
classifiers. The results show up to 20% improvement in F1-
measure in breast cancer, 10% improvement in precision in 
metastatic HCC cancer and 3% improvement in F1-measure 
in squamous lung cancer. Co-Training also outperforms Low 
Density Separation (LDS) approach by around 25% 
improvement in F1-measure in breast cancer. 
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